Xiao Ding

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 10

Top Topics

Iron Deficiency

Papillary Thyroid

Top Venues

Journal of medicinal chemistry

Expert opinion on therapeutic patents

This page only lists publications with an associated author ORCID identifier.

Publications

Jianyu Xu, Xiaoyu Ding, Yanyun Fu, Qingyuan Meng, Ling Wang, Man Zhang, Chenxi Xu, Shan Chen, Alexander Aliper, Feng Ren, Alex Zhavoronkov, Xiao Ding
Discovery of Novel and Potent Prolyl Hydroxylase Domain-Containing Protein (PHD) Inhibitors for The Treatment of Anemia. Journal of medicinal chemistry (2024)
Jianyu Xu, Hongyun Qi, Zhen Wang, Ling Wang, Barbara Steurer, Xin Cai, Jinxin Liu, Alexander Aliper, Man Zhang, Feng Ren, Alex Zhavoronkov, Xiao Ding
Discovery of a Novel and Potent Cyclin-Dependent Kinase 8/19 (CDK8/19) Inhibitor for the Treatment of Cancer. Journal of medicinal chemistry (2024)
Jianyu Xu, Xiaoyu Ding, Yanyun Fu, Qingyuan Meng, Ling Wang, Man Zhang, Chenxi Xu, Shan Chen, Alexander Aliper, Feng Ren, Alex Zhavoronkov, Xiao Ding
Discovery of Novel and Potent Prolyl Hydroxylase Domain-Containing Protein (PHD) Inhibitors for The Treatment of Anemia. Journal of medicinal chemistry 67 (2) (2024)
Jianyu Xu, Xiaoyu Ding, Yanyun Fu, Qingyuan Meng, Ling Wang, Man Zhang, Chenxi Xu, Shan Chen, Alexander Aliper, Feng Ren, Alex Zhavoronkov, Xiao Ding
Discovery of Novel and Potent Prolyl Hydroxylase Domain-Containing Protein (PHD) Inhibitors for The Treatment of Anemia. Journal of medicinal chemistry 67 (2) (2024)
Jianyu Xu, Hongyun Qi, Zhen Wang, Ling Wang, Barbara Steurer, Xin Cai, Jinxin Liu, Alexander Aliper, Man Zhang, Feng Ren, Alex Zhavoronkov, Xiao Ding
Discovery of a Novel and Potent Cyclin-Dependent Kinase 8/19 (CDK8/19) Inhibitor for the Treatment of Cancer. Journal of medicinal chemistry 67 (10) (2024)
Yazhou Wang, Chao Wang, Tingting Liu, Hongyun Qi, Shan Chen, Xin Cai, Man Zhang, Alexander Aliper, Feng Ren, Xiao Ding, Alex Zhavoronkov
Discovery of Tetrahydropyrazolopyrazine Derivatives as Potent and Selective MYT1 Inhibitors for the Treatment of Cancer. Journal of medicinal chemistry 67 (1) (2023)
Yazhou Wang, Chao Wang, Tingting Liu, Hongyun Qi, Shan Chen, Xin Cai, Man Zhang, Alexander Aliper, Feng Ren, Xiao Ding, Alex Zhavoronkov
Discovery of Tetrahydropyrazolopyrazine Derivatives as Potent and Selective MYT1 Inhibitors for the Treatment of Cancer. Journal of medicinal chemistry 67 (1) (2023)
Yazhou Wang, Chao Wang, Tingting Liu, Hongyun Qi, Shan Chen, Xin Cai, Man Zhang, Alexander Aliper, Feng Ren, Xiao Ding, Alex Zhavoronkov
Discovery of Tetrahydropyrazolopyrazine Derivatives as Potent and Selective MYT1 Inhibitors for the Treatment of Cancer. Journal of medicinal chemistry 67 (1) (2023)
Yazhou Wang, Chao Wang, Tingting Liu, Hongyun Qi, Shan Chen, Xin Cai, Man Zhang, Alexander Aliper, Feng Ren, Xiao Ding, Alex Zhavoronkov
Discovery of Tetrahydropyrazolopyrazine Derivatives as Potent and Selective MYT1 Inhibitors for the Treatment of Cancer. Journal of medicinal chemistry (2023)
Jun Wu, Xiao Ding, Xuefei Tan
A patent review of aldosterone synthase inhibitors (2014-present). Expert opinion on therapeutic patents (2021)